Scholar Rock Holding (SRRK) Profit After Tax Growth (1y) (2018 - 2026)
Scholar Rock Holding (SRRK) Profit After Tax Growth (1y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
PAT Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
-88.68% |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
66.06% |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
17.05% |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
-290.15% |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
-129.68% |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
-632.44% |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
59.59% |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
Scholar Rock Holding |
5.62 Bn |
5.14 Bn |
- |
-41.20% |
| Date | Value |
|---|
| Mar 31, 2026 |
-41.20% |
| Dec 31, 2025 |
-36.88% |
| Sep 30, 2025 |
-58.53% |
| Jun 30, 2025 |
-88.06% |
| Mar 31, 2025 |
-31.43% |
| Dec 31, 2024 |
-44.07% |
| Sep 30, 2024 |
-52.22% |
| Jun 30, 2024 |
-54.27% |
| Mar 31, 2024 |
-44.37% |
| Dec 31, 2023 |
-17.50% |
| Sep 30, 2023 |
2.17% |
| Jun 30, 2023 |
13.81% |
| Mar 31, 2023 |
-395.33% |
| Dec 31, 2022 |
-9.30% |
| Sep 30, 2022 |
-15.44% |
| Jun 30, 2022 |
-43.29% |
| Mar 31, 2022 |
71.27% |
| Dec 31, 2021 |
-35.16% |
| Sep 30, 2021 |
-59.19% |
| Jun 30, 2021 |
-59.26% |
